234 related articles for article (PubMed ID: 33676744)
21. Rare presentation of inflammatory myofibroblastic tumor on a digit.
West CE; Workman A; Moody T; Hosler GA
J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372
[TBL] [Abstract][Full Text] [Related]
22. Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review.
Durham C; Clemons M; Alias A; Konduri K
Cureus; 2022 Jul; 14(7):e27223. PubMed ID: 36035049
[TBL] [Abstract][Full Text] [Related]
23. PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors.
Cha YJ; Shim HS
Oncotarget; 2017 Oct; 8(52):89465-89474. PubMed ID: 29163763
[TBL] [Abstract][Full Text] [Related]
24. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::NTRK3 fusion.
Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H
Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182
[TBL] [Abstract][Full Text] [Related]
25. DCTN1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS.
Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ
Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367
[TBL] [Abstract][Full Text] [Related]
26. Crizotinib combined with bronchoscopic interventional treatment in ALK-positive inflammatory myofibroblastic tumor of left main stem bronchus: a case report.
Zhang P; Wang C; Lv Z; Du M; Xu R
J Cardiothorac Surg; 2023 Nov; 18(1):318. PubMed ID: 37950305
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
[TBL] [Abstract][Full Text] [Related]
28. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
Mossé YP; Voss SD; Lim MS; Rolland D; Minard CG; Fox E; Adamson P; Wilner K; Blaney SM; Weigel BJ
J Clin Oncol; 2017 Oct; 35(28):3215-3221. PubMed ID: 28787259
[TBL] [Abstract][Full Text] [Related]
29. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Mossé YP; Lim MS; Voss SD; Wilner K; Ruffner K; Laliberte J; Rolland D; Balis FM; Maris JM; Weigel BJ; Ingle AM; Ahern C; Adamson PC; Blaney SM
Lancet Oncol; 2013 May; 14(6):472-80. PubMed ID: 23598171
[TBL] [Abstract][Full Text] [Related]
30. Crizotinib in ALK
Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
[TBL] [Abstract][Full Text] [Related]
31. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Schöffski P; Kubickova M; Wozniak A; Blay JY; Strauss SJ; Stacchiotti S; Switaj T; Bücklein V; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Lee CJ; Speetjens FM; Nzokirantevye A; Neven A; Kasper B
Eur J Cancer; 2021 Oct; 156():12-23. PubMed ID: 34392187
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.
Ogata M; Hatachi Y; Ogata T; Satake H; Imai Y; Yasui H
Intern Med; 2019 Apr; 58(7):1029-1032. PubMed ID: 30449794
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
[TBL] [Abstract][Full Text] [Related]
34. Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.
Lowe E; Mossé YP
Oncol Ther; 2024 Apr; ():. PubMed ID: 38676786
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumour: a case report.
Tong D; Chisholm J; Madden B; Ahmed M
J Med Case Rep; 2024 Apr; 18(1):167. PubMed ID: 38594735
[TBL] [Abstract][Full Text] [Related]
36. Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors.
Devins KM; Samore W; Nielsen GP; Deshpande V; Oliva E
Mod Pathol; 2023 Jun; 36(6):100143. PubMed ID: 36806735
[TBL] [Abstract][Full Text] [Related]
37. Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.
Wong HH; Bentley H; Bulusu VR; Anyaegbu G; Watkins J; Horan G; Hatcher H
Anticancer Drugs; 2020 Nov; 31(10):1106-1110. PubMed ID: 32868646
[TBL] [Abstract][Full Text] [Related]
38. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy.
Rao K; Farooki S; Guest E; Chastain K; Gener M; Akangire G
J Pediatr Hematol Oncol; 2021 May; 43(4):e521-e524. PubMed ID: 32769570
[TBL] [Abstract][Full Text] [Related]
40. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH
Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]